A SARS-CoV-2 recombinant spike protein vaccine (S-268019-b) for COVID-19 prevention during the Omicron-dominant period: A phase 3, randomised, placebo-controlled clinical trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A SARS-CoV-2 recombinant spike protein vaccine (S-268019-b) for COVID-19 prevention during the Omicron-dominant period: A phase 3, randomised, placebo-controlled clinical trial

Published:2024-06 Issue:17 Volume:42 Page:3699-3709
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Dinh Thiem Vu,Van Anh Pham Thi,Van Men Chu,Hung Do Thai,Pollard Andrew J.^ORCID,Kamitani Akari,Tada Yukio,Fukuyama Hidenori^ORCID,Iwasaki Yuka^ORCID,Ariyasu Mari,Sonoyama Takuhiro

Publisher

Elsevier BV

Reference33 articles.

1. Aleem A, Akbar Samad AB, Vaqar S. Emerging variants of SARS-CoV-2 and novel therapeutics against coronavirus (COVID-19) [Updated May 8, 2023]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 January. Available from: https://www.ncbi.nlm.nih.gov/books/NBK570580/.

2. World Health Organization. WHO coronavirus (COVID-19) dashboard; 2023. https://covid19.who.int/. Accessed July 12, 2023.

3. World Heath Organization. WHO coronavirus (COVID-19) dashboard Viet Nam situation; 2023. https://covid19.who.int/region/wpro/country/vn. Accessed July 18, 2023.

4. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review;Fiolet;Clin Microbiol Infect,2022

5. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines;Meo;Eur Rev Med Pharmacol Sci,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP